<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017259"><a href="http://purl.obolibrary.org/obo/MONDO_0017259">MONDO:0017259</a></h3>
<p><strong>Label:</strong> systemic diseases with anterior uveitis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018305">MONDO:0018305</a> (chronic granulomatous disease), <a href="http://purl.obolibrary.org/obo/MONDO_0019338">MONDO:0019338</a> (sarcoidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019432">MONDO:0019432</a> (rheumatoid factor-negative juvenile idiopathic arthritis), <a href="http://purl.obolibrary.org/obo/MONDO_0019433">MONDO:0019433</a> (Oligoarticular juvenile idiopathic arthritis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_181000">OMIM:181000</a>, <a href="http://purl.obolibrary.org/obo/OMIM_306400">OMIM:306400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85408">Orphanet:85408</a>, <a href="http://purl.obolibrary.org/obo/OMIM_138990">OMIM:138990</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85410">Orphanet:85410</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612387">OMIM:612387</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613960">OMIM:613960</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612388">OMIM:612388</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233710">OMIM:233710</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233700">OMIM:233700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233690">OMIM:233690</a>, <a href="http://www.orpha.net/ORDO/Orphanet_797">Orphanet:797</a>, <a href="http://www.orpha.net/ORDO/Orphanet_379">Orphanet:379</a>, <a href="http://purl.obolibrary.org/obo/OMIM_233670">OMIM:233670</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002955">HP:0002955</a> (Granulomatosis) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007499">HP:0007499</a> (Recurrent staphylococcal infections) and <a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0007499">HP:0007499</a> (Recurrent staphylococcal infections) and <a href="http://purl.obolibrary.org/obo/HP_0011990">HP:0011990</a> (Abnormality of neutrophil physiology) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002719">HP:0002719</a> (Recurrent infections) and <a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002719">HP:0002719</a> (Recurrent infections) and <a href="http://purl.obolibrary.org/obo/HP_0011990">HP:0011990</a> (Abnormality of neutrophil physiology) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002718">HP:0002718</a> (Recurrent bacterial infections) and <a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002718">HP:0002718</a> (Recurrent bacterial infections) and <a href="http://purl.obolibrary.org/obo/HP_0011990">HP:0011990</a> (Abnormality of neutrophil physiology) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) 67.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010977">HP:0010977</a> (Abnormality of phagocytes) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003203">HP:0003203</a> (Negative nitroblue tetrazolium reduction test) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002723">HP:0002723</a> (Absence of bactericidal oxidative 'respiratory burst' in phagocytes) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 64.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011993">HP:0011993</a> (Impaired neutrophil bactericidal activity) and <a href="http://purl.obolibrary.org/obo/HP_0100658">HP:0100658</a> (Cellulitis) 64.29%</li>
</ul>
</body>
</html>
